25 results
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
lymphoma (DLBCL) - Management ... Matthew Ho, MD PhD ... lymphoma #DLBCL #Management ... Treatment #Algorithm #oncology ... #hematology
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
suspect underlying hematologic ... Matthew Ho, MD PhD ... Syndrome #HES #Hematology ... eosinophils #diagnosis #management
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Matthew Ho, MD PhD ... Hodgkins #Lymphoma #oncology ... #Hematology #management
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Treatment #Algorithm #management ... #hematology #oncology
Raynaud's in Dark Skin
In general for darker skin, most aspects of the skin exam stay constant
Raynaud's in Dark Skin ... aspects of the skin ... #dermatology #brown ... #clinical #photos ... #hands #rheumatology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Diagnosis and Management ... acute leukemia Management ... MDS #Diagnosis #Management ... #treatment #hematology ... #oncology
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
Diagnosis and Management ... Matthew Ho, MD PhD ... Differential #Diagnosis #Management ... #Algorithm #hematology
Melanoma Treatment Algorithm

Resectable vs Inoperable Disease

Matthew Ho, MD PhD @MatthewHoMD and Aakash Desai, MD @ADesaiMD

#Melanoma #Treatment
Matthew Ho, MD PhD ... Treatment #Algorithm #Management ... #dermatology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Anticoagulation #Management ... #Hematology #Oncology
Cryofibrinogenemia Summary

Cryofibrinogenemia Epidemiology:
 • 40-70 years with a modest female predominance

Cryofibrinogenemia:
 • The precipitation of a
Vascular reactivity (Skin ... Warfarin-induced skin ... Atherosclerotic PVD ... Cryofibrinogenemia #diagnosis #rheumatology ... #hematology